Rick Doblin
Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and dog.
Multidisciplinary Assoc. for Psychedelic Studies
Unbound Biology: Psychedelic Science Meets Breakthrough Biotech
-
The psychedelic renaissance is colliding with the frontiers of biotechnology, opening bold new pathways for healing, consciousness, and brain health. In this thought-provoking session, Gul Dolen, professor of behavioral and systems neuroscience at UC Berkeley, joins visionary investor Steve Jurvetson and Rick Doblin, founder of MAPS and pioneer of psychedelic-assisted therapy. Together, they’ll explore how synthetic biology, precision medicine, and neuroplasticity research are converging to unlock the therapeutic potential of psychedelics. From molecular design to regulatory breakthroughs, this conversation dives into the science, ethics, and future of reprogramming the mind.
